Department of Medicine, Baylor College of Medicine, Houston, Texas.
Section of Cardiology, University of Alabama, Birmingham, Alabama.
J Am Coll Cardiol. 2014 Dec 30;64(25):2743-9. doi: 10.1016/j.jacc.2014.09.067.
Although obesity is an independent risk factor for heart failure (HF), once HF is established, obesity is associated with lower mortality. It is unclear if the weight loss due to advanced HF leads to this paradoxical finding.
This study sought to evaluate the prognostic impact of pre-morbid obesity in patients with HF.
In the ARIC (Atherosclerosis Risk In Communities) study, we used body mass index (BMI) measured ≥6 months before incident HF (pre-morbid BMI) to evaluate the association of overweight (BMI 25 to <30 kg/m(2)) and obesity (BMI ≥30 kg/m(2)) compared with normal BMI (18.5 to <25 kg/m(2)) with mortality after incident HF.
Among 1,487 patients with incident HF, 35% were overweight and 47% were obese by pre-morbid BMI measured 4.3 ± 3.1 years before HF diagnosis. Over 10-year follow-up after incident HF, 43% of patients died. After adjustment for demographics and comorbidities, being pre-morbidly overweight (hazard ratio [HR]: 0.72; 95% confidence interval [CI]: 0.58 to 0.90; p = 0.004) or obese (HR: 0.70; 95% CI: 0.56 to 0.87; p = 0.001) had a protective association with survival compared with normal BMI. The protective effect of overweight and obesity was consistent across subgroups on the basis of a history of cancer, smoking, and diabetes.
Our results, for the first time, demonstrate that patients who were overweight or obese before HF development have lower mortality after HF diagnosis compared with normal BMI patients. Thus, weight loss due to advanced HF may not completely explain the protective effect of higher BMI in HF patients.
尽管肥胖是心力衰竭(HF)的独立危险因素,但一旦 HF 确立,肥胖与较低的死亡率相关。目前尚不清楚是否是由于晚期 HF 导致的体重减轻导致了这一矛盾的发现。
本研究旨在评估 HF 患者的肥胖前期对预后的影响。
在 ARIC(社区动脉粥样硬化风险研究)研究中,我们使用 HF 发病前≥6 个月时测量的体重指数(BMI)(肥胖前期 BMI)来评估超重(BMI 为 25 至<30 kg/m²)和肥胖(BMI ≥30 kg/m²)与正常 BMI(18.5 至<25 kg/m²)与 HF 发病后死亡率之间的相关性。
在 1487 例 HF 患者中,35%的患者超重,47%的患者肥胖,这是通过 HF 诊断前 4.3±3.1 年测量的肥胖前期 BMI 确定的。在 HF 发病后 10 年的随访期间,有 43%的患者死亡。在调整了人口统计学和合并症后,肥胖前期超重(危险比[HR]:0.72;95%置信区间[CI]:0.58 至 0.90;p=0.004)或肥胖(HR:0.70;95%CI:0.56 至 0.87;p=0.001)与生存有保护作用,与正常 BMI 相比。超重和肥胖的保护作用在基于癌症、吸烟和糖尿病病史的亚组中是一致的。
我们的研究结果首次表明,HF 发病前超重或肥胖的患者 HF 诊断后死亡率低于正常 BMI 患者。因此,由于晚期 HF 导致的体重减轻可能并不能完全解释 HF 患者 BMI 较高的保护作用。